This finding may provide a novel cellular and molecular mechanism for the involvement of ERVWE1 in the etiology of schizophrenia and open new possibilities for drug development targeting ERVWE1 and ALKBH5 to treat schizophrenia patients (Fig. 9). The gene discussed is ERVW-1; the disease is schizophrenia.